News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agenus Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
Massachusetts’ Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring
March 30, 2017
·
3 min read
Drug Development
Massachusetts’ Agenus Quietly Discloses Failure of Cancer Vaccine Trial
February 22, 2017
·
2 min read
Genetown
2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now
August 19, 2016
·
3 min read
Bio NC
7 Biotech Stocks Investors Should Keep Their Eye On in 2017
August 3, 2016
·
3 min read
Deals
Looking at the Odds, Pfizer, Incyte or Merck & Co. Will Gobble Up Tiny Agenus
June 14, 2016
·
3 min read
Genetown
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share
May 31, 2016
·
3 min read
Genetown
Organovo’s 3D Bioprinting May Be Sexy, But Agenus and Sorrento May Be Better Buys
March 2, 2016
·
4 min read
Drug Development
Agenus Acquires PhosImmune in $44.9 Million Deal
December 28, 2015
·
2 min read
Genetown
Agenus Trades Away Future Royalties on Sales of GlaxoSmithKline Drug for $115 Million
September 9, 2015
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
May 11, 2026
·
15 min read
Press Releases
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
May 5, 2026
·
3 min read
Press Releases
Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026
April 22, 2026
·
5 min read
Press Releases
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
April 21, 2026
·
7 min read
Press Releases
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
April 3, 2026
·
4 min read
Press Releases
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
April 2, 2026
·
6 min read
Press Releases
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access
March 27, 2026
·
4 min read
Press Releases
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
March 18, 2026
·
5 min read
Press Releases
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
March 16, 2026
·
12 min read
Press Releases
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
March 10, 2026
·
6 min read
